This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Pharmaceutical Compliance Congress (PCC) 2026
April 27-29, 2026
The Ritz-Carlton, Tysons Corner | McLean, VAMcLean, Virginia

Katherine Matos
Associate GC, Product and Medical Affairs at Definium Therapeutics and Former Senior Counsel, Office of Counsel to the Inspector General of the U.S. Dept. of Health & Human Services
Speaker

Profile

Katherine Matos is currently Associate General Counsel at Definium Therapeutics, a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders. Katherine began her career at the U.S. Department of Health and Human Services Office of Inspector General, where she represented the agency in multi-district litigation, monitored Corporate Integrity Agreements, and was lead author of “Practical Guidance for Health Care Governing Boards on Compliance Oversight.” Katherine’s practice has expanded to include compliance program design, investigations, commercial legal, privacy law, and intellectual property. Katherine holds a CIPP/US certification from the International Association of Privacy Professionals (IAPP).

Agenda Sessions

  • OIG's Compliance Crosshairs: What Pharma Must Prioritize Now

    10:10am